cepharanthine has been researched along with Glioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, T; Hidaka, K; Kohno, K; Koike, K; Kubo, T; Kuwano, M; Mori, T; Ohga, T; Wada, M | 1 |
| Fukumoto, M; Hashimoto, N; Kono, K; Mori, H; Takahashi, JA; Ueba, T | 1 |
2 other study(ies) available for cepharanthine and Glioma
| Article | Year |
|---|---|
Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
Topics: Alkaloids; Antigens, Neoplasm; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Dihydropyridines; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Doxorubicin; Drug Resistance, Multiple; Drug Synergism; Gene Expression; Glioma; Humans; Isoenzymes; Microscopy, Fluorescence; Sulfur Compounds; Tumor Cells, Cultured; Verapamil | 1995 |
Effects of combination chemotherapy with biscoclaurine-derived alkaloid (Cepharanthine) and nimustine hydrochloride on malignant glioma cell lines.
Topics: Alkaloids; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzylisoquinolines; Caspase Inhibitors; Cell Division; Central Nervous System Neoplasms; Genes, p53; Glioma; Humans; Nimustine; Oligopeptides; Tumor Cells, Cultured | 2002 |